🇺🇸 FDA

Drug profile · INN

estropipate

ESTROPIPATE

approved
US status
approved
Patents linked
8
News articles
0

Quick answer

estropipate (ESTROPIPATE) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: vaginal. Current US regulatory status: approved.

Key facts

INN estropipate
Brand ESTROPIPATE
Route VAGINAL
Formulation CREAM
Originator Teva Pharma GmbH

Related patents

Search patents →

  1. US 12410398

    Methods of human retinal progenitor cell isolation and culture

    Expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12398193

    Targeted replacement of endogenous T cell receptors

    Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12397034

    Pharmaceutical composition for promoting neurogenesis and method for promoting neurogenesis and inhibiting senescence of brain neurons

    Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12390427

    Plasminogen activator inhibitor-1 (PAI-1) inhibitor and method of use

    Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12384753

    17-beta-hydroxysteroid dehydrogenase type 13 inhibitors and methods of use thereof

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12370181

    Regimens of estrogen receptor antagonists

    Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12371747

    Methods of reducing immunogenicity against factor VIII in individuals undergoing factor VIII therapy

    Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12365875

    Methods for generating skeletal muscle progenitor cells

    Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is estropipate?

estropipate (ESTROPIPATE) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: vaginal. Current US regulatory status: approved.

What is the brand name for estropipate?

ESTROPIPATE is a marketed brand name for estropipate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of estropipate?

estropipate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.